Advertisement

Differential associations between glomerular filtration rate and duration of obesity depending on the presence or absence of left ventricular diastolic dysfunction

Published:February 27, 2016DOI:https://doi.org/10.1016/j.ejim.2016.02.016

      Highlights

      • There is no consensus formula for measuring glomerular filtration rate in obesity.
      • Obesity is not always associated with renal hyperfiltration.
      • Obesity-associated diastolic dysfunction may precede chronic kidney disease.

      Abstract

      Background

      A robust and consistent association between increasing body mass index (BMI) and chronic kidney disease (CKD) has been reported in several observational studies. Obesity remains the main preventable risk factor for CKD because it largely mediates diabetes and hypertension, the 2 most common etiologies for end-stage kidney disease (ESKD). Obesity is associated weakly with early stages of kidney disease but strongly with kidney progression to ESKD, even after adjustment for hypertension and diabetes.

      Aim

      To assess the relationship between estimated glomerular filtration rate (eGFR) and trans-thoracic echocardiography left ventricular function parameters in a cohort of patients with obesity.

      Materials & methods

      Cross-sectional study involving 324 obese (BMI = 44.0 ± 2.2 Kg/m2) apparently healthy asymptomatic patients with an eGFR >60 ml/min/1.73 m2. Each patient underwent transthoracic echocardiography and a blood testing. The eGFR was addressed by the CKD-EPI formula.

      Results

      All patients had a normal systolic function whereas 24.5% disclosed diastolic dysfunction (DD). Hypertension and type 2 diabetes mellitus prevalence were 34.5% and 4.5% (respectively). All patients disclosed an eGFR >60 ml/min while none of them disclosed hyperfiltration (eGFR >120 ml/min). eGFR correlated inversely with BMI and the duration of obesity and positively with diastolic function parameters (P < 0.001 for all, respectively). Patients with diastolic dysfunction displayed lower eGFR (P < 0.0005) and longer duration of obesity (P < 0.0005).

      Conclusions

      Obesity and its duration are likely to impose hemodynamic changes affecting simultaneously both heart (diastolic dysfunction) and kidney (decreased glomerular filtration rate). Larger prospective studies are warranted.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ogden C.L.
        • Carroll M.D.
        • Curtin L.R.
        • et al.
        Prevalence of overweight and obesity in the United States, 1999–2004.
        JAMA. 2006; 295: 1549-1555
        • Mokdad A.H.
        • Bowman B.A.
        • Ford E.S.
        • et al.
        The continuing epidemics of obesity and diabetes in the United States.
        JAMA. 2001; 286: 1195-1200
        • MacLaughlin H.L.
        • Hall W.L.
        • Sanders T.A.
        • Macdougall I.C.
        Risk for chronic kidney disease increases with obesity: Health Survey for England 2010.
        Public Health Nutr. Mar 2015; 6: 1-6
        • Cohen E.
        • Fraser A.
        • Goldberg E.
        • Milo G.
        • Garty M.
        • Krause I.
        Association between the body mass index and chronic kidney disease in men and women. A population-based study from Israel.
        Nephrol Dial Transplant. Nov 2013; 28iv130-
        • Kramer H.J.
        • Saranathan A.
        • Luke A.
        • et al.
        Increasing body mass index and obesity in the incident ESRD population.
        J Am Soc Nephrol. 2006; 17: 1453-1459
        • US Renal Data System
        USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States.
        National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD2010
        • Ribstein J.
        • du Cailar G.
        • Mimran A.
        Combined renal effects of overweight and hipertensión.
        Hypertension. 1995 Oct; 26: 610-615
        • Wickman C.
        • Kramer H.
        Obesity and kidney disease: potential mechanisms.
        Semin Nephrol. 2013 Jan; 33: 14-22
        • Bose B.
        • Cattran D.
        • Toronto Glomerulonephritis Registry
        Glomerular diseases: FSGS.
        Clin J Am Soc Nephrol. 2014 Mar; 9: 626-632
        • de Vries A.P.
        • Ruggenenti P.
        • Ruan X.Z.
        • Praga M.
        • Cruzado J.M.
        • Bajema I.M.
        • et al.
        Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease.
        Lancet Diabetes Endocrinol. 2014 May; 2: 417-426
        • Mysliwiec P.
        • Jasiewicz P.
        • Hady H.R.
        • Choromanska B.
        • Mroczko B.
        • Mysliwiec H.
        • et al.
        Creatinine or cystatin C — which is a better index of renal function in morbid obesity?.
        Adv Med Sci. 2013; 58: 376-381
        • Levey A.S.
        • Stevens L.A.
        • Schmid C.H.
        • Zhang Y.L.
        • Castro III, A.F.
        • Feldman H.I.
        • et al.
        A new equation to estimate glomerular filtration rate.
        Ann Intern Med. 2009; 150: 604-612
      1. Stevens LA et al. Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) study equations for estimating GFR levels above 60 mL/min/1.73 m2. AJKD 56(3):486–495.

        • Hubert H.B.
        • Feinleib M.
        • McNamara P.M.
        • Castelli W.P.
        Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.
        Circulation. 1983; 67: 968-977
        • McMurray J.J.
        Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15,000 middle-aged men and women (the Renfrew-Paisley Study).
        Eur Heart J. 2006; 27: 96-106
        • Ounpuu S.
        • Negassa A.
        • Yusuf S.
        INTER-HEART: a global study of risk factors for acute myocardial infarction.
        Am Heart J. 2001; 141: 711-721
        • Kenchaiah S.
        • Evans J.C.
        • Levy D.
        • et al.
        Obesity and the risk of heart failure.
        N Engl J Med. 2002; 347: 305-313
        • Pascual M.
        • Pascual D.A.
        • Soria F.
        • et al.
        Effects of isolated obesity on systolic and diastolic left ventricular function.
        Heart. 2003; 89: 1152-1156
        • Scaglione R.
        • Dichiara M.A.
        • Indovina A.
        • et al.
        Left ventricular diastolic and systolic function in normotensive obese subjects: influence of degree and duration of obesity.
        Eur Heart J. 1992; 13: 738-742
        • Alpert M.A.
        • Lambert C.R.
        • Panayiotou H.
        • Terry B.E.
        • Cohen M.V.
        • Massey C.V.
        • et al.
        Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss.
        Am J Cardiol. 1995; 76: 1194-1197
        • Ybarra J.
        • Romeo J.H.
        • Férnandez S.
        • Sanchez-Hernandez J.
        The influence of obesity duration on left ventricular mass, volume and function: a pilot study.
        Health. 2012; 4
        • Chakko S.
        Diastolic dysfunction.
        in: Alpert M.A.A.J. Obesity and Ventricular Function in Man. Armonk, New York, NY1998: 57-76
        • Zarich S.W.
        • Kowalchuk G.J.
        • McGuire M.P.
        • Benotti P.N.
        • Mascioli E.A.
        • Nesto R.W.
        Left ventricular filling abnormalities in asymptomatic morbid obesity.
        Am J Cardiol. 1991; 68: 377-381
        • Mancia G.
        • de Backer G.
        • Dominiczak A.
        • et al.
        Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
        J Hypertens. 2007; 25: 1105-1187
        • Teichholz L.E.
        • Kreulen T.H.
        • Herman M.V.
        • et al.
        Problems in echocardiographic volume determinations: echocardiographic–angiographic correlation in the presence of absence of asynergy.
        Am J Cardiol. 1976; 37: 7-11
        • Devereux R.B.
        • Reiche N.
        Echocardiographic determination of left ventricular mass in man. Anatomic evaluation of the method.
        Circulation. 1987; 59: 956-960
        • Levy D.
        • Savage D.D.
        • Garrison R.J.
        • et al.
        Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study.
        Am J Cardiol. 1987; 59: 956-960
        • Quinones M.A.
        • Otto C.M.
        • Stoddard M.
        • et al.
        Recommendations for quantification of Doppler echocardiogaphy. A report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiogaphy.
        J Am Soc Echocardiogr. 2002; 15: 167-184
        • Alam M.
        • Wardell J.
        • Andersson E.
        • Samad B.A.
        • Nordlander R.
        Characteristics of mitral and tricúspide annular velocities determined by pulsed wave Doppler tissue imaging in healthy subjects.
        J Am Soc Echocardiogr. 1999; 12: 618-628
        • Ommen S.R.
        • Nishimura R.A.
        • Appleton C.P.
        • et al.
        Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study.
        Circulation. 2000; 102: 1788-1794
        • Alpert M.A.
        Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome.
        Am J Med Sci. 2001; 321: 225-236
        • Chagnac A.
        • Weinstein T.
        • Korzets A.
        • Ramadan E.
        • Hirsch J.
        • Gafter U.
        Glomerular hemodynamics in severe obesity.
        Am J Physiol Renal Physiol. 2000; 278: F817-F822
        • Bosma R.J.
        • van de Heide J.J.
        • Oosterop E.J.
        • De JonG P.E.
        • Navis G.
        Body mass index is associated with altered hemodynamics in non-obese healthy subjects.
        Kidney Int. 2004; 65: 259-265
        • Hall J.E.
        • Kuo J.J.
        • da Silva A.A.
        • de Paula R.B.
        • Liu J.
        • Tallam L.
        Obesity-associated hypertension and kidney disease.
        Curr Opin Nephrol Hypertens. 2003; 12: 195-200
        • Levey A.S.
        • Kramer H.
        Obesity, glomerular hyperfiltration, and the surface area correction.
        Am J Kidney Dis. 2010; 56: 255-288
        • Eriksen B.O.
        • Melsom T.
        • Mathisen U.D.
        • Jenssen T.G.
        • Solbu M.D.
        • Toft I.
        GFR normalized to total body water allows comparisons across genders and body sizes.
        J Am Soc Nephrol. 2011; 22: 1517-1525
        • Schmieder R.E.
        • Veelken R.
        • Schobel H.
        • Dominiak P.
        • Mann J.F.
        • Luft F.C.
        Glomerular hyperfiltration during sympathetic nervous system activation in early essential hypertension.
        J Am Soc Nephrol. 1997; 8: 893-900
        • Hsieh M.C.
        • Su H.M.
        • Wang S.Y.
        • Tsai D.H.
        • Lin S.D.
        • Chen S.C.
        • et al.
        Significant correlation between left ventricular systolic and diastolic dysfunction and decreased glomerular filtration rate.
        Am J Cardiol. Mar 1 2013; 111: 712-716
        • Sato B.
        • Yoshikawa D.
        • Ishii H.
        • Suzuki S.
        • Inoue Y.
        • Takeshita K.
        • et al.
        Relation of plasma indoxyl sulfate levels and estimated glomerular filtration rate to left ventricular diastolic dysfunction.
        Am J Cardiol. Mar 1 2013; 111: 712-716
        • Gelber R.P.
        • Kurth T.
        • Kausz A.T.
        • et al.
        Association between body mass index and CKD in apparently healthy men.
        Am J Kidney Dis. 2005; 46: 871-880
        • Kramer H.
        • Luke A.
        • Bidani A.
        • Cao G.
        • Cooper R.
        • McGee D.
        Obesity and prevalent and incident CKD: the hypertension detection and follow-up program.
        Am J Kidney Dis. 2005; 46: 587-594
        • Fox C.S.
        • Larson M.G.
        • Leip E.P.
        • Culleton B.
        • Wilson P.W.
        • Levy D.
        Predictors of new-onset kidney disease in a community-based population.
        JAMA. 2004; 291: 844-850
        • Ejerblad E.
        • Fored C.M.
        • Lindblad P.
        • Fryzek J.
        • McLaughlin J.K.
        • Nyren O.
        Obesity and risk for chronic renal failure.
        J Am Soc Nephrol. 2006; 17: 1695-1702
        • Hsu C.Y.
        • McCulloch C.E.
        • Iribarren C.
        • Darbinian J.
        • Go A.S.
        Body mass index and risk for end-stage renal disease.
        Ann Intern Med. 2006; 144: 21-28
        • Messerli F.H.
        Cardiopathy of obesity: a not-so-Victorian disease.
        N Engl J Med. 1986; 314: 378-380
        • Ku C.S.
        • Lin S.L.
        • Wang D.J.
        • Chang S.K.
        • Lee W.J.
        Left ventricular filling in young normotensive obese adults.
        Am J Cardiol. 1994; 73: 613-615
        • Garza C.A.
        • Pellikka P.A.
        • Somers V.K.
        • Sarr M.G.
        • Collazo-Clavell M.L.
        • Korenfeld Y.
        • et al.
        Structural and functional changes in left and right ventricles after major weight loss following bariatric surgery for morbid obesity.
        Am J Cardiol. Feb 2010 15; 105: 550-556
        • Aggarwal R.
        • Harling L.
        • Efthimiou E.
        • Darzi A.
        • Athanasiou T.
        • Ashrafian H.
        The effects of bariatric surgery on cardiac structure and function: a systematic review of cardiac imaging outcomes.
        Obes Surg. Sep 2 2015; ([Epub ahead of print])
        • Kibar A.E.
        • Paç F.A.
        • Oflaz M.B.
        • Ballı S.
        • Ece I.
        Echocardiographic evaluation of left ventricular function in normotensive obese children: a comparative analysis according to body mass index.
        Turk Kardiyol Dern Ars. 2012 Jun; 40: 337-346
        • Lima-Leopoldo A.P.
        • Leopoldo A.S.
        • da Silva D.C.
        • do Nascimento A.F.
        • de Campos D.H.
        • Luvizotto R.A.
        • et al.
        Long-term obesity promotes alterations in diastolic function induced by reduction of phospholamban phosphorylation at serine-16 without affecting calcium handling.
        J Appl Physiol. Sep 15 2014; 117: 669-678